Bioactive peptide with anti-photoaging effect, composition and application
The small molecule biologically active peptides AVSAANDPNGI and GNTELQAA isolated and synthesized from phycocyanin are formed to form a composition with tyrosinase inhibitory activity, which solves the problems of poor stability of phycocyanin and insufficient safety of tyrosinase inhibitors. , achieved effective anti-photoaging effects, laying the foundation for the high added value utilization of phycocyanin.
Patent Information
- Application Number
- CN202411377807.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-09-30
AI Technical Summary
In the prior art, phycocyanin has poor stability and is not easily digested and absorbed by the human body, which limits its application in the fields of food health and medicine, and the safety and practicality of existing tyrosinase inhibitors are poor. It is difficult to effectively prevent skin aging.
By isolating and purifying small molecule bioactive peptides AVSAANDPNGI and GNTELQAA with anti-photoaging effects from phycocyanin, the enzyme-solving, ultrafiltration, gel chromatography, liquid chromatography and other technologies were separated and identified, and the liquid was passed Chemical synthesis is carried out using combined technology to form a bioactive peptide composition with better tyrosinase inhibitory activity.
The obtained bioactive peptide composition has significant tyrosinase inhibitory activity, is significantly better than a single peptide, has good anti-photoaging effects, is suitable for food, drugs or health products, and promotes high addition of phycocyanin. Value utilization and functional active peptide research and development and application.
Smart Images

Figure CN119019543A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of bioactive peptides, and in particular relates to a bioactive peptide with anti-photoaging effect, a composition and an application thereof. Background Art
[0002] Photoaging is a common type of skin aging caused by the sun, especially long-term UV radiation, which is mainly manifested in epidermal hyperplasia, skin sagging and darkening, and coarse wrinkles. Tyrosinase is an important rate-limiting enzyme in the reaction of melanin production and is widely distributed in the human body. The large accumulation of melanin in the human body can cause diseases such as pigment spots and malignant melanoma. Reducing the activity of tyrosinase can achieve the effect of preventing skin diseases. However, many new tyrosinase inhibitors reported in recent years have poor safety and practicality. Therefore, safer natural extracts have become the research direction for the development of new tyrosinase inhibitors.
[0003] Phycocyanin is a functional protein in Spirulina, which has anti-tumor, anti-inflammatory and antioxidant effects. However, as a biological macromolecule, phycocyanin has poor stability, is easily inactivated, and is not easily digested and absorbed by the human body. These characteristics limit its further application in the fields of food, health care and medicine.
[0004] Bioactive peptides are specific protein fragments that have a positive impact on the body's health. Compared with complete proteins, small molecule peptide fragments have multiple advantages: they are easier to be absorbed and utilized by the human body, have high activity, and can play a physiological role even at low concentrations; they have a small molecular weight, are easy to modify and transform, and can be obtained through artificial chemical synthesis and other means. Compared with single amino acids, small molecule peptides not only have special physiological activities, but also have unique advantages in absorption channels and speed.
[0005] The development of small molecule bioactive peptides with anti-photoaging effects based on phycocyanin has laid the foundation for the high value-added utilization of phycocyanin and the promotion of the research and development and application of anti-photoaging active peptide products. Summary of the invention
[0006] In view of the problems existing in the prior art, the purpose of the present invention is to provide a bioactive peptide, composition and application with anti-photoaging effect.
[0007] In order to achieve the above object, the present invention adopts the following technical solution:
[0008] A bioactive peptide with anti-photoaging effect, wherein the amino acid sequence of the bioactive peptide is at least one of AVSAANDPNGI and GNTELQAA.
[0009] A bioactive peptide composition with anti-photoaging effect, wherein the effective components of the composition are bioactive peptides with amino acid sequences of AVSAANDPNGI and GNTELQAA.
[0010] Based on the above scheme, the mass ratio of AVSAANDPNGI and GNTELQAA is 1:1.
[0011] Based on the above scheme, the anti-photoaging effect is the effect of inhibiting tyrosinase.
[0012] Application of the above bioactive peptide composition with anti-photoaging effect in the preparation of products with anti-photoaging effect.
[0013] Based on the above scheme, the product includes food, medicine or health care product.
[0014] Based on the above solution, the product further comprises auxiliary materials acceptable in pharmacy, food or health care products.
[0015] Advantages of the technical solution of the present invention:
[0016] The present invention separates and purifies two bioactive peptides with anti-photoaging efficacy from phycocyanin by enzymatic hydrolysis, ultrafiltration, gel chromatography, and liquid chromatography separation techniques, and preliminarily identifies its components and sequences by liquid chromatography-mass spectrometry. Chemical synthesis is performed based on the identified peptide sequence, and the tyrosinase inhibitory activity of the single peptide segment and the composite peptide segment of the synthetic peptide segment is detected. These bioactive peptides and composite peptide segments all have good tyrosinase inhibitory activity, and the tyrosinase inhibitory activity of the composite peptide segment is significantly better than that of the single peptide segment. The bioactive peptides obtained by the present invention have good application prospects in the preparation of products with anti-photoaging efficacy, and lay a foundation for the high added value utilization of phycocyanin and the promotion of the research and development and application of functional active peptides. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 Degree of hydrolysis of different phycocyanin hydrolysates;
[0018] Figure 2 Determination results of tyrosinase inhibition rate of different phycocyanin hydrolysates;
[0019] Figure 3 Electrophoretic analysis of phycocyanin (lane 1) and the product obtained by trypsin digestion of phycocyanin (lane 2) (protein markers have molecular weights of 3.3-20.1 KDa);
[0020] Figure 4 The results of the determination of tyrosinase inhibition rate of products with different molecular weights obtained by trypsin hydrolysis of phycocyanin;
[0021] Figure 5 Superdex of components with molecular weight <3KDa TM Increase 10 / 300GL gel chromatogram;
[0022] Figure 6 From Superdex TM The results of the determination of tyrosinase inhibition rate of each component collected during the Increase 10 / 300GL filtration;
[0023] Figure 7 Superdex loaded on C18 column TM RP-HPLC chromatogram of the active components of Increase 10 / 300GL;
[0024] Figure 8 The results of tyrosinase inhibition rate determination of each component collected from RP-HPLC;
[0025] Fig. 9 Mass spectrometry analysis results of phycocyanin peptides AVSAANDPNGI;
[0026] Fig.10 Mass spectrometry analysis results of phycocyanin peptide GNTELQAA;
[0027] Fig.11 Molecular weight plot of peptide AVSAANDPNGI mass spectra;
[0028] Fig.12 Molecular weight plot of the mass spectrum of peptide GNTELQAA;
[0029] Fig.13 The results of determination of tyrosinase inhibition rate of chemically synthesized peptides AVSAANDPNGI, GNTELQAA and composite peptides (AVSAANDPNGI+GNTELQAA). DETAILED DESCRIPTION
[0030] The terms used in the present invention, unless otherwise specified, generally have the meanings commonly understood by those of ordinary skill in the art. The present invention will be further described in detail below in conjunction with specific examples and with reference to data. The following examples are intended to illustrate the present invention and are not intended to limit the scope of the present invention in any way.
[0031] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The experimental materials, reagents, drugs, etc. used in the following examples, unless otherwise specified, can all be purchased through general channels.
[0032] Determination of the degree of hydrolysis of phycocyanin
[0033] The determination of phycocyanin hydrolysis was carried out using the o-phthalaldehyde (OPA) method, and the specific method is as follows: 80 mg of OPA was dissolved in 2 mL of β-mercaptoethanol, 5 mL of 10% SDS (w / v) and 92.8 mL of 0.1 M sodium tetraborate to prepare 100 mL of OPA reagent solution. 4 mL of phycocyanin hydrolysate hydrolyzed by different proteases was mixed with 4 mL of OPA reagent, incubated at room temperature for 2 minutes, and the absorbance at a wavelength of 340 nm was measured.
[0034] Phycocyanin was placed in 6M HCl and reacted at 4°C for 24 hours. The amount of free amino acids was determined using a serine standard curve as the amount of free amino acids produced by the complete hydrolysis of phycocyanin.
[0035] The degree of hydrolysis of phycocyanin was calculated according to the following formula:
[0036] Degree of hydrolysis (%) = [(NH 2 ) t -(NH 2 ) t0 )] / (NH 2 ) T
[0037] Where: (NH 2 ) t represents the amount of free amino acids in the enzymatic hydrolysis product at time t; (NH 2 ) t0 Represents the amount of free amino acids that have not been hydrolyzed by enzymes; (NH 2 ) T Represents the amount of free amino acids after complete hydrolysis.
[0038] To determine the tyrosinase inhibitory activity, take the following steps:
[0039] First, mark the positions of A1, A2, A3 and A4 in a 96-well plate, add 40 μL of sample solution (1 mg / mL) to A1 and A2, 40 μL of phosphate buffer to A3 and A4, 40 μL of tyrosinase (2 mg / mL) to A1 and A3, and 40 μL of phosphate buffer to A2 and A4, mix in the wells of the 96-well plate, and shake gently for 30 seconds. After incubation at 37°C for 5 minutes, add 50 μL of L-tyrosine (0.2 mg / mL) to A1 and A3, and 50 μL of phosphate buffer to A2 and A4. In order to produce the maximum coloration of the reaction mixture, react at the same temperature for 25 minutes. Then measure the absorbance of the sample at 290 nm. Each sample is in triplicate. The inhibition of tyrosinase is determined by the residual activity of the negative control. The test sample uses the buffer solution instead of the control, and the enzyme solution is replaced by the blank buffer solution.
[0040] The anti-photoaging activity was calculated using the following formula:
[0041] Tyrosinase inhibitory activity (%)=[(A1-A2)-(A3-A4)] / (A1-A2)
[0042] A1 is the absorbance of the sample group containing tyrosinase, A2 is the absorbance of the sample group without tyrosinase, A3 is the PBS buffer containing tyrosinase, and A4 is the PBS buffer.
[0043] The phycocyanin used in the following examples was purchased from Zhejiang Binmei Biotechnology Co., Ltd.
[0044] Example 1
[0045] A bioactive peptide with anti-photoaging effect, wherein the amino acid sequence of the bioactive peptide is shown in at least one of SEQ ID NO: 1 to SEQ ID NO: 2.
[0046] SEQ ID NO:1AVSAANDPNGI
[0047] SEQ ID NO:2GNTELQAA
[0048] Example 2
[0049] A method for preparing a bioactive peptide with anti-photoaging effect can be directly synthesized by an existing method such as chemical synthesis, or can be extracted and prepared by the following method. The specific steps are as follows:
[0050] (1) Take 5 g of phycocyanin powder and prepare a protein solution with a concentration of 5% (w / v) using ultrapure water.
[0051] Trypsin was added to the prepared phycocyanin aqueous solution at an enzyme to substrate ratio of 1:100 (w / w), and the enzymatic hydrolysis was carried out at 37°C for 6 hours. During the process, 0.05 mol / L NaOH and HCl were used to adjust the pH value of the reaction system. After the enzymatic hydrolysis reaction was completed, the enzymatic hydrolyzate was boiled at 100°C for 10 minutes to terminate the reaction. The enzymatic hydrolyzate was centrifuged at 6000r / min and 4°C for 15 minutes, and the supernatant was retained.
[0052] Effects of different proteases on the hydrolysis degree of phycocyanin hydrolysates and the inhibitory effect on tyrosinase activity related to anti-photoaging activity
[0053] Alkaline protease, papain, trypsin, pepsin, neutral protease and acid protease were used to enzymolyze phycocyanin. The temperature and pH of the enzymolysis were all at the optimal temperature and pH of each protease (Table 1). The other conditions were the same as those of trypsin. After the enzymolysis was completed, the effects of different proteases on the degree of hydrolysis (DH,%) of the phycocyanin hydrolyzate and the inhibitory effect of tyrosinase activity related to anti-photoaging activity were determined. The results are shown in Figure 1 The results showed that trypsin had a good hydrolysis ability ( Figure 1 ), and the hydrolyzate has significant anti-photoaging effect ( Figure 2 ).
[0054] Table 1 Optimal temperature and pH of different proteases
[0055]
[0056] (2) The supernatant obtained by trypsin enzymatic hydrolysis was fractionated into different molecular weights using ultrafiltration centrifuge tubes, with a molecular weight cutoff of 10kDa and 3kDa. The fractions were collected as follows: >10kDa, the peptide was retained but not passed through the 10kDa membrane; 3-10kDa, the peptide penetrated the 10kDa membrane but not the 3kDa membrane; <3kDa, the peptide penetrated the 3kDa membrane. Thus, the protease hydrolysate with a molecular weight range of <3kDa, 3-10kDa, and >10kDa was obtained ( Figure 3 ).
[0057] The inhibitory effect of different molecular weight components on tyrosinase activity related to anti-photoaging activity was determined. The results showed that protein peptides with a smaller molecular weight <3KDa showed better inhibitory effect on tyrosinase ( Figure 4 ).
[0058] (4) Take the <3kDa enzymatic solution and run it on Superdex TMThe product was further purified by filtration on an Increase 10 / 300GL gel permeation column (10×300 mm). The column was eluted with deionized water (pH 7) and fractions were collected at a flow rate of 1 mL / min. Fractions were detected at 280 nm.
[0059] According to the time sequence of the peaks, three peptide components were collected and named F1, F2 and F3 ( Figure 5 The inhibitory effects of the three polypeptide components on tyrosinase activity were determined, and the results showed that the three components all had the ability to inhibit tyrosinase ( Figure 6 ), among which component F2 has the most significant effect.
[0060] (5) Using reverse phase HPLC in C 18 Fraction F2 obtained from gel permeation chromatography was further purified on a chromatographic column. A linear gradient of acetonitrile (0–40%) containing 0.1% trifluoroacetic acid (TFA) was used at a flow rate of 1 mL / min. The elution peak was detected at 215 nm and the active peak was concentrated using a rotary evaporator. The potent peak was collected and lyophilized. The amino acid sequence of the final purified peptide was analyzed.
[0061] According to the time sequence of the peaks, five polypeptide components were collected and named F2-Ⅰ, F2-Ⅱ, F2-Ⅲ, F2-Ⅳ and F2-Ⅴ ( Figure 7 The active peak was concentrated by rotary evaporator. The tyrosinase inhibition rate was determined. The results showed that F2-Ⅰ had a good effect on tyrosinase inhibition ( Figure 8 ).
[0062] (6) The amino acid sequence of F2-Ⅰ was determined.
[0063] The peptide sample obtained in step (5) was centrifugally dried, redissolved in Nano-LC mobile phase A (0.1% formic acid / water), bottled and loaded for online LCMS analysis. The liquid phase was Easy nLC 1200 nanoliter liquid phase system. The dissolved sample was loaded onto a nanoViper C18 pre-column (3μm, 100A) in an appropriate volume, and then washed and desalted with a volume of 20μl. After the sample was desalted and retained on the pre-column, it was separated by an analytical column. The specifications of the analytical column were C18 reverse phase chromatography columns (Acclaim PepMap RSLC, 75μm×25cm C18-2μm 100A). The gradient used in the experiment was a 30-min increase in mobile phase B (80% acetonitrile, 0.1% formic acid) from 5% to 38%. The mass spectrometer used a ThermoFisher Q Exactive system (ThermoFisher, USA) combined with a nanospray NanoFlex ion source (ThermoFisher, USA), with a spray voltage of 1.9 kV and an ion transfer tube heating temperature of 275 °C. The mass spectrometer scan mode was in the information-dependent acquisition mode (DDA, Data Dependent Analysis), with a primary mass spectrometer scan resolution of 70000, a scan range of 350-2000 m / z, and a maximum injection time of 100 ms. In each DDA cycle, up to 20 secondary spectra with charges of 2+ to 5+ were collected, and the maximum injection time of the secondary mass spectrometer ions was 50 ms. The collision cell energy (high-energy collision-induced dissociation, HCD) was set to 28 eV, applicable to all precursor ions, and the dynamic exclusion was set to 25 s.
[0064] As a result, two peptides were obtained (Table 2). The secondary mass spectrum analysis showed that the peptides had a molecular weight of 1028.4774 and the sequences were AVSAANDPNGI( Fig. 9 ); The peptide with a molecular weight of 802.3821 has a sequence of GNTELQAA. ( Fig.10 ).
[0065] Table 2 List of amino acid sequences of component F2-Ⅰ determined by LC-MS
[0066]
[0067] The sequences AVSAANDPNGI and GNTELQAA in Table 2 above were chemically synthesized, and the mass spectrometry molecular weights of the two peptides obtained were as shown in Fig.11 and Fig.12 shown.
[0068] Example 3
[0069] A composition with anti-photoaging efficacy, wherein the active ingredients of the composition are AVSAANDPNGI peptide segment and GNTELQAA peptide segment, wherein the mass ratio of the AVSAANDPNGI peptide segment to the GNTELQAA peptide segment is 1:1.
[0070] The inhibitory ability of single peptides AVSAANDPNGI, GNTELQAA and composite peptides AVSAANDPNGI+GNTELQAA to tyrosinase was determined. The concentration of single peptides was 1 mg / mL; in the composite peptides, the mass ratio of the two peptides was 1:1, and the concentration of each peptide was 1 mg / mL.
[0071] The results are as follows Fig.13 As shown in the figure, the inhibitory effects of single peptides AVSAANDPNGI and GNTELQAA on tyrosinase were 33.19% and 52.35% respectively. The inhibitory effect of composite peptide AVSAANDPNGI+GNTELQAA on tyrosinase was 88.24%. It can be seen that the inhibitory effect of composite peptide on tyrosinase is significantly better than that of single peptide, and has better anti-photoaging effect.
[0072] The above is only a preferred embodiment of the present invention, and does not limit the present invention in other forms. Any technician familiar with the profession may use the above disclosed technical content to change or modify it into an equivalent embodiment with equivalent changes. However, any simple modification, equivalent change and modification made to the above embodiment according to the technical essence of the present invention without departing from the technical solution of the present invention still belongs to the protection scope of the technical solution of the present invention.
Claims
1. Bioactive peptides with anti-photoaging effects, It is characterized in that The amino acid sequence of the bioactive peptide is at least one of AVSAANDPNGI and GNTELQAA.
2. Bioactive peptide compositions with anti-photoaging effects, It is characterized in that The effective components of the composition are bioactive peptides with amino acid sequences of AVSAANDPNGI and GNTELQAA.
3. The bioactive peptide composition with anti-photoaging effect according to claim 2, It is characterized in that The mass ratio of AVSAANDPNGI to GNTELQAA is 1:
1.
4. The bioactive peptide composition with anti-photoaging effect according to claim 3, It is characterized in that The anti-photoaging effect is the effect of inhibiting tyrosinase.
5. Use of the bioactive peptide composition with anti-photoaging efficacy according to any one of claims 2 to 4 in the preparation of a product with anti-photoaging efficacy.
6. The use according to claim 5, It is characterized in that The products include food, medicine or health products.
7. The use according to claim 6, It is characterized in that The product also contains auxiliary materials acceptable in medicine, food or health care products.
Citation Information
Patent Citations
Application of phycocyanin nanoparticles in preparation of sunscreen preparation
CN114557907A
Laser welding System and Method for Liquefied Gas Cargo Containment System
KR1020220135489A
System and method for security threats anomaly detection based on artificial intelligence
KR102433830B1
Cosmetic composition with excellent effect of skin elasticity, moisture, whitening, anti aging and wrinkle improvement
KR102506099B1
Cited By
Small-molecule active peptide, composition and application of small-molecule active peptide in preparation of product with antioxidant and hypoglycemic effects
CN119241656A
